In a CARACAL meeting, the European Commission has introduced the latest update of the ‘Rolling List of (groups of) substances for restriction’, which is part of the Restrictions Roadmap. HEAL has provided feedback to the updated rolling list and note concerns on the repeated delays in the implementation of restrictions of groups of substances that have been included in the Roadmap for several years.
This leaflet briefly describes the evidence that hormonally active chemicals may be implicated in the deterioration of male reproductive health, gives some statistics on the rates of malformation of the penis, undscended testicles, sperm counts and cancer of the testicle. Written for those affected and a wide public audience, the leaflet explains the hypothesis of testicular dysgenesis syndrome (TDS) and how all the above problems may be linked to exposure to these chemicals during a male baby’s pre-natal development. The leaflet also provides advice on what people can do to minimize their exposure.
